Overview

Following year-on-year success, CHI presents the Sixth Annual Immunogenicity and Bioassay Summit 2014: 3 conferences, 45+ presentations, 15+ interactive breakout round table and panel discussions, exhibit/poster hall, and networking opportunities. Immunogenicity Prediction & Mitigation is designed to help investigators design and select non-immunogenic products for early-stage decision making, while Immunogenicity Assessment & Clinical Relevance and Optimizing Bioassays for Biologics will enable investigators to overcome the complexities of bioassays and immunoassays and develop programs that ensure their products are safe and efficacious, and satisfy regulatory requirements. Register today so you can join 250+ of your peers at the Number 1 Immunogenicity Summit in the U.S.


Venue: Hyatt Regency Bethesda
Location: One Bethesda Metro Center, Bethesda, MD
Country: United States

Organiser Contact Details:
Cambridge Healthtech Institute
T: 781-972-5400
kwaterman@healthtech.com